Related references
Note: Only part of the references are listed.Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-beta (A beta) Plaque Load and A beta-Synthesizing and A beta-Degrading Enzymes in Frontal Cortex
Emma L. Ashby et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Spatial training promotes short-term survival and neuron-like differentiation of newborn cells in Aβ1-42-injected rats
Juan Zeng et al.
NEUROBIOLOGY OF AGING (2016)
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Miriam Ries et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
Yong Li et al.
NEURAL PLASTICITY (2016)
WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers
Jessica Y. Vargas et al.
EXPERIMENTAL NEUROLOGY (2015)
Stable isotope labelling methods in mass spectrometry-based quantitative-proteomics
Osama Chahrour et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model
Anne-Caroline Schmoele et al.
NEUROBIOLOGY OF AGING (2015)
NEURONAL EXPRESSION OF CB2 CANNABINOID RECEPTOR mRNAs IN THE MOUSE HIPPOCAMPUS
Y. Li et al.
NEUROSCIENCE (2015)
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Hai-Ying Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications
Niraj Kumar Jha et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi
Lai-Ling Du et al.
AGE (2014)
Dual roles for autophagy: Degradation and secretion of Alzheimer's disease Aβ peptide
Per Nilsson et al.
BIOESSAYS (2014)
In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
Claudia Balducci et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Effect of troxerutin on synaptic plasticity of hippocampal dentate gyrus neuronsina β-amyloid model of Alzheimer's disease: An electrophysiological study
Shirin Babri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Quantification of the Brain Proteome in Alzheimer's Disease Using Multiplexed Mass Spectrometry
Sravani Musunuri et al.
JOURNAL OF PROTEOME RESEARCH (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease
Takahisa Kanekiyo et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors
Maria S. Garcia-Gutierrez et al.
NEUROPHARMACOLOGY (2013)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Xiao-Hong Li et al.
NEUROBIOLOGY OF AGING (2012)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
NEUROCHEMICAL BASIS OF CANNABIS ADDICTION
R. Maldonado et al.
NEUROSCIENCE (2011)
Wnt-5a occludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
Waldo Cerpa et al.
MOLECULAR NEURODEGENERATION (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
Rosa Maria Tolon et al.
BRAIN RESEARCH (2009)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Amyloid β-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo
Jian-Mei Zhang et al.
SYNAPSE (2006)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
GK Gouras et al.
NEUROBIOLOGY OF AGING (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease
PG Kehoe et al.
HUMAN GENETICS (2004)
Clearing amyloid through the blood-brain barrier
BV Zlokovic
JOURNAL OF NEUROCHEMISTRY (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Aβ25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil
DB Freir et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Long-term potentiation in the hippocampal CA1 area and dentate gyrus plays different roles in spatial learning
T Okada et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
